About the conference
The 9th Annual Medical Director Forum has been developed to provide cutting-edge clinical updates to individuals responsible for managing large patient populations. Faculty — who are comprised of nationally recognized practitioners and thought leaders — will discuss relevant research, evidence-based treatment guidelines and their application, new medications and adherence issues, and innovations for optimizing patient care, amongst other selected topics.
After completion of this activity, the participant should be able to:
- Recognize the clinical and economic impacts of antibiotic-resistant infections that threaten the health care system and relate these to prevention and intervention strategies for the management of these infections.
- Discuss the impact of the physician-burnout epidemic on physicians, patients, and the health care system, along with factors that lead to — and potential interventions that may reduce — the severe stress among this profession.
- Describe the challenges of medication nonadherence, its effects on financial and health outcomes, and potential strategies to enhance compliance.
- Review the mechanism of action of recent medications being used to treat type 2 diabetes, including DPP-4 (dipeptidyl peptidase-4) and SGLT2 (sodium-glucose cotransporter 2) inhibitors, and their significant metabolic benefits.
- Outline current treatment guidelines and best practices that offer management strategies for arthritis and coronary heart disease.
- Explain testing technologies for gynecologic cancers and the role of genetic testing for inherited cancer susceptibility.
This conference has been designed for Optum, UnitedHealthcare, and UnitedHealth Group medical directors, as well as medical directors and other physicians that manage large patient populations and/or their benefits worldwide.
** Refer to the Continuing Education page for a listing of certifications that have been applied for and/or approved for this conference.
Need CE credits? Earn up to 6.5 continuing education credits at this year's forum. >Learn more